Synergistic effect of hyperforin and paclitaxel on growth inhibition, apoptotic mediator activation in MCF-7 human breast cancer cells
The role of hyperforin in combination anticancer therapy remain unknown. In this study, several doses of combination treatment (paclitaxel and hyperforin) were introduced to the Michigan Cancer Foundation (MCF)-7 cell culture for 24 h. The effectiveness of the drug’s combination effect was determine...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Taylor & Francis Group
2021-01-01
|
| Serie: | Journal of Taibah University for Science |
| Soggetti: | |
| Accesso online: | http://dx.doi.org/10.1080/16583655.2021.2010910 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|